Zoíray Technologies Inc. is developing a multiplexed immunoassay platform for life science research and clinical diagnostics.
Immunoassays that identify the presence of specific protein biomarkers in blood, urine, or saliva constitute a vital tool in modern healthcare. Zoíray’s technology enables many immunoassays to be multiplexed on to one small disposable chip. While multiplexed immunoassays are emerging in life science research, existing techniques require a labeling step that adds significant variability, inhibits high density arrays, and provides a less quantifiable signal. Existing label-free detection technology is too costly and complex for many life science research labs let alone clinical use. With simple, inexpensive, label-free protein array detection, Zoíray expects to make a strong impact in molecular in vitro diagnostics with tests that provide far more information than is currently feasible.